CTCF and breast carcinoma: Furthermore, silencing of tumor suppressor miR-125b1 in breast cancer due to epigenetic phenomena that result in the methylation of CpG islands preventing CTCF binding, leads to aberrant cell proliferation (108, 109, 111).